SCHEMBL5668680

SCHEMBL5668680

CCCCCCCOc1c[c]ccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
NR5A1 Q13285 1/20 0.42
FAAH O00519 6/20 0.41
TDP1 Q9NUW8 1/20 0.40
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
MEN1 O00255 1/20 0.39
NR1I2 O75469 1/20 0.39
LMNA P02545 1/20 0.39
CHRM2 P08172 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADRA2A P08913 1/20 0.39
MAPT P10636 1/20 0.39
OPRK1 P41145 1/20 0.39
HTR2B P41595 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KMT2A Q03164 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
TSHR P16473 2/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5182869 1.00 L3MBTL1 (0.44) L3MBTL1NR5A1FAAHTDP1THRA
SCHEMBL14814379 0.88 L3MBTL1 (0.40) L3MBTL1FAAHTDP1MEN1MAPT
SCHEMBL9699861 0.87 L3MBTL1 (0.44) L3MBTL1NR5A1FAAHTDP1THRA
SCHEMBL1228883 0.87 L3MBTL1 (0.44) L3MBTL1NR5A1FAAHTDP1THRA
SCHEMBL27294182 0.87 L3MBTL1 (0.44) L3MBTL1NR5A1FAAHTDP1THRA
SCHEMBL9699956 0.87 L3MBTL1 (0.44) L3MBTL1NR5A1FAAHTDP1THRA
SCHEMBL27501834 0.85 L3MBTL1 (0.45) L3MBTL1NR5A1TDP1THRATHRB
SCHEMBL17416897 0.84 NR5A1 (0.42) NR5A1THRATHRBMEN1NR1I2
SCHEMBL3458097 0.84 NR5A1 (0.42) NR5A1THRATHRBMEN1NR1I2
SCHEMBL6200775 0.84 NR5A1 (0.42) NR5A1THRATHRBMEN1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1729755-A1 METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2006-12-13 EP disclosed
WO-2005070407-A1 METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2005-08-04 WO disclosed